Skip to main content
. 2020 Mar 6;12(3):237. doi: 10.3390/pharmaceutics12030237

Figure 7.

Figure 7

Schematic illustration of the five-compartment model to describe the proposed kinetic processes occurring in the BiPHa+ dissolution from dispersing of the ritonavir-amorphous solid dispersion (ASD) formulation to ritonavir partitioning into the organic (1-decanol) layer.